Atlas Trials

DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients

Clinical trial NCT02834468 · UNKNOWN

Trial details

NCT number
NCT02834468
Sponsor
Shandong University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2016-06-01
Primary completion
2018-07-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.